Eptifibatide

CHEMBL1174 Phase 4 Approuvé Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

832.0 g/mol

LogP

-2.4

Phase

4

This injectable medication prevents platelets from clumping together to form clots by blocking a key receptor on the platelet surface. It is used to treat acute coronary syndrome and during certain heart procedures.

Masse moléculaire

832,0000 g/mol

LogP

-2,40

TPSA

377,00 Å²

Règle des 5 de Lipinski

Non conforme

Aires thérapeutiques

Systemic Lupus Erythematosus Stroke Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

InChI

InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1

Molecular Formula

C35H49N11O9S2

HBD / HBA

10 / 12

Liaisons Rotatives

10

Atomes Lourds

57

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This injectable medication prevents platelets from clumping together to form clots by blocking a key receptor on the platelet surface. It is used to treat acute coronary syndrome and during certain heart procedures.

Yes, Eptifibatide is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1174. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 448812. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Eptifibatide sur PillFYI

Structure

Données Clés

Formule: C35H49N11O9S2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.